On Invalid Date, Evoke Pharma (NASDAQ: EVOK) reported Q4 2023 earnings per share (EPS) of -$0.59, up 11.32% year over year. Total Evoke Pharma earnings for the quarter were -$1.99 million. In the same quarter last year, Evoke Pharma's earnings per share (EPS) was -$0.53.
As of Q1 2024, Evoke Pharma's earnings has grown year over year. Evoke Pharma's earnings in the past year totalled -$7.79 million.
What is EVOK's earnings date?
Evoke Pharma's earnings date is Invalid Date. Add EVOK to your watchlist to be reminded of EVOK's next earnings announcement.
What was EVOK's revenue last quarter?
On Invalid Date, Evoke Pharma (NASDAQ: EVOK) reported Q4 2023 revenue of $1.68 million up 110.45% year over year. In the same quarter last year, Evoke Pharma's revenue was $796.37 thousand.
What was EVOK's revenue growth in the past year?
As of Q1 2024, Evoke Pharma's revenue has grown 106.51% year over year. This is 96.73 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 9.78%. Evoke Pharma's revenue in the past year totalled $5.18 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.